Response To Oral Agents in Diabetes (ROAD)- Pilot Study

NCT00780715 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Gliclazide MR
DRUG: Sitagliptin
DRUG: Pioglitazone
DRUG: Metformin

Sponsor

University of Dundee